Enter your email address to receive science updates from Juul Labs.
At Juul Labs, scientific research is vitally important, and we are working to expand the body of knowledge around ENDS products, which we believe play a critical role in transitioning adult smokers away from combustible cigarettes. We strive to ask the relevant questions and take direction on what research to conduct from regulators and other public health stakeholders.
We are conducting studies that span nonclinical, clinical, behavioral, and population impact areas of investigation with the goal of better understanding the harm reduction potential of the JUUL System, including its impact on the individual user, its ability to transition adult smokers away from combustible cigarettes, and the net-population impact on public health.
We value scientific exchange and sharing our findings with members of the scientific community. We share the results of our studies with regulators and the public health community through peer-reviewed journals, conference presentations, one-on-one meetings, and this website, which is designed to act as a centralized portal for members of the scientific and public health communities, regulators, and policymakers to learn about the scientific research Juul Labs is conducting.
To date:
Our nonclinical research examines the JUUL e-liquid and aerosol through various analytical, chemistry, and toxicological assessments in laboratory settings. This includes measuring and evaluating the levels of harmful and potentially harmful constituents (HPHCs) identified by FDA that are found in the smoke of combustible cigarettes compared to the aerosol from the JUUL System.
See nonclinical studies
Our clinical studies examine the impact of the JUUL System on human health, including the rate and level of nicotine absorption in the body, product use and puff topography, potential secondhand aerosol exposure in real world settings, and reductions in exposure to chemicals tied to harm. These studies assess the physiological impact on adult smokers and the environmental impact on others by examining the level of exposure to a specific substance and potential harm over time with the JUUL System compared to combustible cigarettes.
See clinical studies
Behavioral factors are critical to understanding the population health impact of the JUUL System among current tobacco product users and nonusers. We have developed an extensive behavioral research program that includes assessments of JUUL System purchasers and general population samples. Epidemiological surveys track patterns of tobacco product use among adult JUUL System users, including their prior cigarette smoking history.
These assessments include measurements of complete switching from combustible cigarettes to the JUUL System and, for adult smokers that are still transitioning from combustible use, reductions in the number of cigarettes consumed. We also assess perceptions of the potential risks associated with the use of JUUL and other tobacco products among both users and nonusers.
Within our behavioral research program, data on over 100,000 adult survey participants has been collected and analyzed.
See behavioral studies
In population impact studies, we use data from our own research, as well as from third parties, to build causal inference, econometric, and population health models that demonstrate the impact of JUUL use, including adult switching, on a wide range of key population-level outcomes. Our population science research also explores the unintended impact of JUUL product use among those who are not our intended users,including those who are underage. Our team also evaluates the impact of policies and interventions such as enhanced access controls and laws and regulations like Tobacco 21, to understand how they can help reduce underage use of tobacco products.
See economics and policy impact studies